Physician profile
David E Auer
NPI 1104878776
$1,124.79
in general payments reported to CMS, 2019-2025
20 companies · $44.92 in 2025
The $44.92 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.14 · 2020: $149 · 2021: $298 · 2022: $240 · 2023: $139 · 2024: $165 · 2025: $44.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $202.22 | 2019-2024 | Mounjaro, Emgality, Jardiance |
| Novo Nordisk INC | $177.36 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $159.69 | 2019-2025 | Farxiga, Airsupra |
| Amgen INC. | $139.45 | 2021-2023 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $116.30 | 2022-2024 | |
| Exact Sciences Corporation | $56.23 | 2024-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $51.96 | 2021-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $28.51 | 2021 | |
| Sanofi Pasteur INC. | $18.67 | 2021 | |
| Glaxosmithkline, LLC. | $18.24 | 2024 | Trelegy Ellipta |
| Amarin Pharma, INC. | $18.12 | 2020 | |
| Abbott Laboratories | $17.46 | 2021 | |
| Dexcom, INC. | $16.91 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $16.60 | 2022 | |
| Abbvie INC. | $15.92 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15.85 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $14.96 | 2019 | |
| Pfizer INC. | $14.82 | 2019 | |
| Seqirus USA INC | $12.94 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Auer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.